•
Allow insertion site to dry completely prior to applying
dressing.
5. Ensure catheter patency prior to use. Do not use syringes
smaller than 10 mL to reduce risk of intraluminal leakage or
catheter rupture.
6. Minimize catheter manipulation throughout procedure to
maintain proper catheter tip position.
7. For blood sampling, temporarily shut off remaining port(s), if
applicable, through which solutions are being infused.
Kits/Sets may not contain all accessory components
detailed in these instructions for use. Become familiar with
instructions for individual component(s) before beginning
the procedure.
A Suggested Procedure:
1. Position patient as appropriate for insertion site.
• Subclavian or Jugular approach: Place patient in slight Trendelenburg position as
tolerated to reduce risk of air embolism and enhance venous filling.
• Femoral approach: Place patient in supine position.
2. Prepare the central venous catheter for insertion by flushing each lumen and clamping
or attaching injection caps to the appropriate extension lines, as required.
Warning: Do not cut catheter to alter length.
3. Prep hemostasis valve cap with appropriate antiseptic per hospital protocol. Include
the exposed portion of the valve on the top of the cap. Occlude hemostasis valve with
sterile-gloved finger.
• With sterile-gloved fingers, peel back tail of peel-away catheter contamination
guard to expose tip of catheter (refer to Figure 1).
• Grasping catheter body, still covered by the peel-away catheter contamination
guard, advance catheter into hemostasis valve. Continue advancing catheter and
peeling away the contamination guard until catheter hub locks on hemostasis valve
(refer to Figure 2).
Use sterile technique.
Figure 1
4. Assess catheter tip placement in compliance with institutional policies and procedures.
5. If catheter tip is malpositioned, assess and replace or reposition according to
institutional policies and procedures.
6. Connect all extension lines to appropriate Luer-Lock line(s), as required. Unused ports
may be "locked" through injection cap(s) using standard hospital protocol. Slide clamps
are provided on extension lines to occlude flow through each lumen during line and
injection cap changes.
Precaution: To minimize the risk of damage to extension lines from excessive
pressure, each clamp must be opened prior to infusing through that lumen.
Catheter Patency:
Maintain catheter patency according to institutional policies, procedures and practice guidelines.
All personnel who care for patients with central venous catheters must be knowledgeable about
effective management to prolong catheter' s dwell time and prevent injury.
Catheter Removal from Access Device Procedure:
1. Position patient as clinically indicated to reduce risk of potential air embolus.
2. Unlock catheter and withdraw catheter from access device. Temporarily cover valve
opening with sterile-gloved finger until obturator is inserted. Apply obturator cap.
Warning: Hemostasis valve must be occluded at all times to reduce the risk of air
embolism or hemorrhage.
For reference literature concerning patient assessment, clinician education,
insertion technique, and potential complications associated with this procedure,
consult standard textbooks, medical literature, and Arrow International LLC website:
www.teleflex.com
A pdf copy of this IFU is located at www.teleflex.com/IFU
This is the "Arrow CVC" Summary of Safety and Clinical Performance (SSCP)
location after the launch of the European Database on Medical Devices/Eudamed:
https://ec.europa.eu/tools/eudamed
For a patient/user/third party in the European Union and in countries with identical
regulatory regime (Regulation 2017/745/EU on Medical Devices); if, during the use
of this device or as a result of its use, a serious incident has occurred, please report
it to the manufacturer and/or its authorized representative and to your national
authority. The contacts of national competent authorities (Vigilance Contact Points)
and further information can be found on the following European Commission website:
https://ec.europa.eu/growth/sectors/medical-devices/contacts_en
2
Figure 2